Suppr超能文献

促血管生成 CXC 趋化因子的差异活性。

Differential activity of pro-angiogenic CXC chemokines.

机构信息

Department of Medicine, Johns Hopkins University, Division of Pulmonary and Critical Care Medicine, Baltimore, MD 21224, USA.

出版信息

Microvasc Res. 2010 Jul;80(1):18-22. doi: 10.1016/j.mvr.2010.01.011. Epub 2010 Feb 6.

Abstract

We showed previously in a mouse model of lung ischemia-induced angiogenesis, enhanced expression of the three ELR+ CXC chemokines (KC, LIX, and MIP-2) and that blockade of the ligand receptor CXCR(2) limited neovascularization. The present study was undertaken to determine the relative abundance and angiogenic potential of the three CXC chemokines and whether RhoA activation explained the measured differences in potencies. We found that LIX showed the greatest absolute amount in the in vivo model 4 h after left pulmonary artery obstruction (LIX>KC>MIP-2; p<0.05). In vitro, LIX induced the greatest degree of arterial endothelial cell chemotaxis and KC was without effect. A significant increase (approximately 40%) in active RhoA was observed with both LIX and MIP-2 compared with vehicle control (p<0.05). On average, LIX induced the greatest amount of tube formation within pleural tissue in culture. Thus, the results of the present study suggest that among the three ELR+ CXC chemokines, LIX predominates in eliciting a pro-angiogenic phenotype.

摘要

我们之前在肺缺血诱导血管生成的小鼠模型中表明,三种 ELR+CXC 趋化因子(KC、LIX 和 MIP-2)的表达增强,并且趋化因子受体 CXCR(2)的阻断限制了新血管生成。本研究旨在确定三种 CXC 趋化因子的相对丰度和血管生成潜力,以及 RhoA 激活是否可以解释所测量的效力差异。我们发现,在左肺动脉阻塞后 4 小时的体内模型中,LIX 表现出最大的绝对量(LIX>KC>MIP-2;p<0.05)。在体外,LIX 诱导动脉内皮细胞趋化作用的程度最大,而 KC 则没有作用。与载体对照相比,LIX 和 MIP-2 观察到活性 RhoA 显著增加(约 40%)(p<0.05)。平均而言,LIX 在胸膜组织中诱导的管形成量最大。因此,本研究的结果表明,在这三种 ELR+CXC 趋化因子中,LIX 在引发促血管生成表型方面占主导地位。

相似文献

1
Differential activity of pro-angiogenic CXC chemokines.促血管生成 CXC 趋化因子的差异活性。
Microvasc Res. 2010 Jul;80(1):18-22. doi: 10.1016/j.mvr.2010.01.011. Epub 2010 Feb 6.
5
The role of CXCR2 in systemic neovascularization of the mouse lung.CXCR2在小鼠肺部系统性新血管形成中的作用。
J Appl Physiol (1985). 2007 Aug;103(2):594-9. doi: 10.1152/japplphysiol.00037.2007. Epub 2007 Jun 7.

引用本文的文献

3
Lymphangiogenesis in rat asthma model.大鼠哮喘模型中的淋巴管生成
Angiogenesis. 2017 Feb;20(1):73-84. doi: 10.1007/s10456-016-9529-2. Epub 2016 Oct 27.
5
Increased hyaluronan fragmentation during pulmonary ischemia.肺缺血时透明质酸片段增加。
Am J Physiol Lung Cell Mol Physiol. 2011 Nov;301(5):L782-8. doi: 10.1152/ajplung.00079.2011. Epub 2011 Aug 5.

本文引用的文献

3
CXCR2 antagonists for the treatment of pulmonary disease.用于治疗肺部疾病的CXCR2拮抗剂。
Pharmacol Ther. 2009 Jan;121(1):55-68. doi: 10.1016/j.pharmthera.2008.10.005. Epub 2008 Oct 31.
4
Chemokines as mediators of neovascularization.趋化因子作为新生血管形成的介质。
Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1928-36. doi: 10.1161/ATVBAHA.108.162925. Epub 2008 Aug 28.
5
Inhibition of CXCR2 attenuates bronchial angiogenesis in the ischemic rat lung.抑制CXCR2可减轻缺血大鼠肺组织中的支气管血管生成。
J Appl Physiol (1985). 2008 May;104(5):1470-5. doi: 10.1152/japplphysiol.00974.2007. Epub 2008 Mar 6.
6
Inflammation and ischemia-induced lung angiogenesis.炎症和缺血诱导的肺血管生成。
Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L351-7. doi: 10.1152/ajplung.00369.2007. Epub 2007 Dec 21.
8
The role of CXCR2 in systemic neovascularization of the mouse lung.CXCR2在小鼠肺部系统性新血管形成中的作用。
J Appl Physiol (1985). 2007 Aug;103(2):594-9. doi: 10.1152/japplphysiol.00037.2007. Epub 2007 Jun 7.
10
Pulmonary ischemia induces lung remodeling and angiogenesis.肺缺血会引发肺重塑和血管生成。
J Appl Physiol (1985). 2006 Feb;100(2):587-93. doi: 10.1152/japplphysiol.00029.2005. Epub 2005 Oct 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验